HC Wainwright Reaffirms Buy Rating for Iovance Biotherapeutics (NASDAQ:IOVA) tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Iovance Biotherapeutics (NASDAQ:IOVA) Shares Gap Down to $13.45 wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Iovance Biotherapeutics (IOVA) Set to Announce Quarterly Earnings on Thursday theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Average Rating of "Buy" by Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) saw a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 48,980,000 shares, a growth of 5.6% from the March 31st total of 46,380,000 shares. Approximately 22.2% of the shares of the company are sold short. Based […]